A detailed history of Powers Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Powers Advisory Group, LLC holds 1,153 shares of AMGN stock, worth $368,475. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,153
Previous 1,048 10.02%
Holding current value
$368,475
Previous $297,000 21.21%
% of portfolio
0.2%
Previous 0.17%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $27,588 - $33,527
105 Added 10.02%
1,153 $360,000
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $48,934 - $59,069
182 Added 21.02%
1,048 $297,000
Q4 2023

Jan 17, 2024

BUY
$255.7 - $288.46 $1,278 - $1,442
5 Added 0.58%
866 $249,000
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $188,257 - $233,727
861 New
861 $231,000
Q1 2023

Apr 13, 2023

BUY
$225.79 - $275.2 $1,128 - $1,376
5 Added 0.59%
851 $205,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $193,759 - $246,194
846 New
846 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Powers Advisory Group, LLC Portfolio

Follow Powers Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Powers Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Powers Advisory Group, LLC with notifications on news.